ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sodium Iodide (131I) for Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-16Y16998
Home | Market Reports | Health| Pharmacy
Global Sodium Iodide 131I for Therapy Market Research Report 2024
BUY CHAPTERS

Global Sodium Iodide (131I) for Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-16Y16998
Report
November 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Curium Pharma
HTA
Jubilant Pharmova
PDRadiopharma Inc.
Yantai Dongcheng Pharmaceutical Group Co
NTP Radioisotopes
International Isotopes Inc.
ANSTO
POLATOM（NCBJ）
Isotope JSC (ROSATOM)

Sodium Iodide (131I) for Therapy Market

The global Sodium Iodide (131I) for Therapy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Sodium Iodide (131I) is a radiopharmaceutical containing the beta- and gamma-emitting radioisotope I-131. After absorption, the iodide is distributed through the extracellular fluid of the body and accumulates in the thyroid gland, thereby allowing the imaging of the thyroid.
In terms of product type, Capsule is the largest segment, with a share over 60%.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Sodium Iodide (131I) for Therapy market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Sodium Iodide (131I) for Therapy Market Report

Report Metric Details
Report Name Sodium Iodide (131I) for Therapy Market
Segment by Type
  • Capsule
  • Solution
Segment by Application
  • Hyperthyroidism Treatment
  • Thyroid Cancer Treatment
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Curium Pharma, HTA Co., Ltd., Jubilant Pharmova, PDRadiopharma Inc., Yantai Dongcheng Pharmaceutical Group Co, NTP Radioisotopes, International Isotopes Inc, ANSTO, POLATOM（NCBJ）, Isotope JSC (Rosatom)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Sodium Iodide (131I) for Therapy study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

What is the Sodium Iodide (131I) for Therapy Market share by type?

Ans: In terms of product type, Capsule is the largest segment, with a share over 60%.

Who are the main players in the Sodium Iodide (131I) for Therapy Market report?

Ans: The main players in the Sodium Iodide (131I) for Therapy Market are Curium Pharma, HTA Co., Ltd., Jubilant Pharmova, PDRadiopharma Inc., Yantai Dongcheng Pharmaceutical Group Co, NTP Radioisotopes, International Isotopes Inc, ANSTO, POLATOM（NCBJ）, Isotope JSC (Rosatom)

What are the Application segmentation covered in the Sodium Iodide (131I) for Therapy Market report?

Ans: The Applications covered in the Sodium Iodide (131I) for Therapy Market report are Hyperthyroidism Treatment, Thyroid Cancer Treatment

What are the Type segmentation covered in the Sodium Iodide (131I) for Therapy Market report?

Ans: The Types covered in the Sodium Iodide (131I) for Therapy Market report are Capsule, Solution

1 Study Coverage
1.1 Introduction to Sodium Iodide (131I) for Therapy: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Sodium Iodide (131I) for Therapy Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Capsule
1.2.3 Solution
1.3 Market Segmentation by Application
1.3.1 Global Sodium Iodide (131I) for Therapy Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hyperthyroidism Treatment
1.3.3 Thyroid Cancer Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sodium Iodide (131I) for Therapy Revenue Estimates and Forecasts 2020-2031
2.2 Global Sodium Iodide (131I) for Therapy Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Sodium Iodide (131I) for Therapy Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Sodium Iodide (131I) for Therapy Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Capsule Market Size by Players
3.3.2 Solution Market Size by Players
3.4 Global Sodium Iodide (131I) for Therapy Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Sodium Iodide (131I) for Therapy Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Sodium Iodide (131I) for Therapy Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Sodium Iodide (131I) for Therapy Market Size by Type (2020-2031)
6.4 North America Sodium Iodide (131I) for Therapy Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Sodium Iodide (131I) for Therapy Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Sodium Iodide (131I) for Therapy Market Size by Type (2020-2031)
7.4 Europe Sodium Iodide (131I) for Therapy Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Sodium Iodide (131I) for Therapy Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Sodium Iodide (131I) for Therapy Market Size by Type (2020-2031)
8.4 Asia-Pacific Sodium Iodide (131I) for Therapy Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Sodium Iodide (131I) for Therapy Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Sodium Iodide (131I) for Therapy Market Size by Type (2020-2031)
9.4 Central and South America Sodium Iodide (131I) for Therapy Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Sodium Iodide (131I) for Therapy Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Sodium Iodide (131I) for Therapy Market Size by Type (2020-2031)
10.4 Middle East and Africa Sodium Iodide (131I) for Therapy Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Sodium Iodide (131I) for Therapy Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Curium Pharma
11.1.1 Curium Pharma Corporation Information
11.1.2 Curium Pharma Business Overview
11.1.3 Curium Pharma Sodium Iodide (131I) for Therapy Product Features and Attributes
11.1.4 Curium Pharma Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.1.5 Curium Pharma Sodium Iodide (131I) for Therapy Revenue by Product in 2024
11.1.6 Curium Pharma Sodium Iodide (131I) for Therapy Revenue by Application in 2024
11.1.7 Curium Pharma Sodium Iodide (131I) for Therapy Revenue by Geographic Area in 2024
11.1.8 Curium Pharma Sodium Iodide (131I) for Therapy SWOT Analysis
11.1.9 Curium Pharma Recent Developments
11.2 HTA Co., Ltd.
11.2.1 HTA Co., Ltd. Corporation Information
11.2.2 HTA Co., Ltd. Business Overview
11.2.3 HTA Co., Ltd. Sodium Iodide (131I) for Therapy Product Features and Attributes
11.2.4 HTA Co., Ltd. Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.2.5 HTA Co., Ltd. Sodium Iodide (131I) for Therapy Revenue by Product in 2024
11.2.6 HTA Co., Ltd. Sodium Iodide (131I) for Therapy Revenue by Application in 2024
11.2.7 HTA Co., Ltd. Sodium Iodide (131I) for Therapy Revenue by Geographic Area in 2024
11.2.8 HTA Co., Ltd. Sodium Iodide (131I) for Therapy SWOT Analysis
11.2.9 HTA Co., Ltd. Recent Developments
11.3 Jubilant Pharmova
11.3.1 Jubilant Pharmova Corporation Information
11.3.2 Jubilant Pharmova Business Overview
11.3.3 Jubilant Pharmova Sodium Iodide (131I) for Therapy Product Features and Attributes
11.3.4 Jubilant Pharmova Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.3.5 Jubilant Pharmova Sodium Iodide (131I) for Therapy Revenue by Product in 2024
11.3.6 Jubilant Pharmova Sodium Iodide (131I) for Therapy Revenue by Application in 2024
11.3.7 Jubilant Pharmova Sodium Iodide (131I) for Therapy Revenue by Geographic Area in 2024
11.3.8 Jubilant Pharmova Sodium Iodide (131I) for Therapy SWOT Analysis
11.3.9 Jubilant Pharmova Recent Developments
11.4 PDRadiopharma Inc.
11.4.1 PDRadiopharma Inc. Corporation Information
11.4.2 PDRadiopharma Inc. Business Overview
11.4.3 PDRadiopharma Inc. Sodium Iodide (131I) for Therapy Product Features and Attributes
11.4.4 PDRadiopharma Inc. Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.4.5 PDRadiopharma Inc. Sodium Iodide (131I) for Therapy Revenue by Product in 2024
11.4.6 PDRadiopharma Inc. Sodium Iodide (131I) for Therapy Revenue by Application in 2024
11.4.7 PDRadiopharma Inc. Sodium Iodide (131I) for Therapy Revenue by Geographic Area in 2024
11.4.8 PDRadiopharma Inc. Sodium Iodide (131I) for Therapy SWOT Analysis
11.4.9 PDRadiopharma Inc. Recent Developments
11.5 Yantai Dongcheng Pharmaceutical Group Co
11.5.1 Yantai Dongcheng Pharmaceutical Group Co Corporation Information
11.5.2 Yantai Dongcheng Pharmaceutical Group Co Business Overview
11.5.3 Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy Product Features and Attributes
11.5.4 Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.5.5 Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy Revenue by Product in 2024
11.5.6 Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy Revenue by Application in 2024
11.5.7 Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy Revenue by Geographic Area in 2024
11.5.8 Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy SWOT Analysis
11.5.9 Yantai Dongcheng Pharmaceutical Group Co Recent Developments
11.6 NTP Radioisotopes
11.6.1 NTP Radioisotopes Corporation Information
11.6.2 NTP Radioisotopes Business Overview
11.6.3 NTP Radioisotopes Sodium Iodide (131I) for Therapy Product Features and Attributes
11.6.4 NTP Radioisotopes Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.6.5 NTP Radioisotopes Recent Developments
11.7 International Isotopes Inc
11.7.1 International Isotopes Inc Corporation Information
11.7.2 International Isotopes Inc Business Overview
11.7.3 International Isotopes Inc Sodium Iodide (131I) for Therapy Product Features and Attributes
11.7.4 International Isotopes Inc Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.7.5 International Isotopes Inc Recent Developments
11.8 ANSTO
11.8.1 ANSTO Corporation Information
11.8.2 ANSTO Business Overview
11.8.3 ANSTO Sodium Iodide (131I) for Therapy Product Features and Attributes
11.8.4 ANSTO Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.8.5 ANSTO Recent Developments
11.9 POLATOM（NCBJ）
11.9.1 POLATOM（NCBJ） Corporation Information
11.9.2 POLATOM（NCBJ） Business Overview
11.9.3 POLATOM（NCBJ） Sodium Iodide (131I) for Therapy Product Features and Attributes
11.9.4 POLATOM（NCBJ） Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.9.5 POLATOM（NCBJ） Recent Developments
11.10 Isotope JSC (Rosatom)
11.10.1 Isotope JSC (Rosatom) Corporation Information
11.10.2 Isotope JSC (Rosatom) Business Overview
11.10.3 Isotope JSC (Rosatom) Sodium Iodide (131I) for Therapy Product Features and Attributes
11.10.4 Isotope JSC (Rosatom) Sodium Iodide (131I) for Therapy Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Sodium Iodide (131I) for TherapyIndustry Chain Analysis
12.1 Sodium Iodide (131I) for Therapy Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Sodium Iodide (131I) for Therapy Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Sodium Iodide (131I) for Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Curium Pharma
HTA
Jubilant Pharmova
PDRadiopharma Inc.
Yantai Dongcheng Pharmaceutical Group Co
NTP Radioisotopes
International Isotopes Inc.
ANSTO
POLATOM（NCBJ）
Isotope JSC (ROSATOM)
List of Tables
 Table 1. Global Sodium Iodide (131I) for Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Sodium Iodide (131I) for Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Sodium Iodide (131I) for Therapy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Sodium Iodide (131I) for Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Sodium Iodide (131I) for Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Sodium Iodide (131I) for Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Sodium Iodide (131I) for Therapy Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Sodium Iodide (131I) for Therapy by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sodium Iodide (131I) for Therapy as of 2024)
 Table 11. Global Sodium Iodide (131I) for Therapy Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Sodium Iodide (131I) for Therapy Companies Headquarters
 Table 13. Global Sodium Iodide (131I) for Therapy Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Sodium Iodide (131I) for Therapy Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Sodium Iodide (131I) for Therapy Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Sodium Iodide (131I) for Therapy Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Sodium Iodide (131I) for Therapy Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Sodium Iodide (131I) for Therapy High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Sodium Iodide (131I) for Therapy Growth Accelerators and Market Barriers
 Table 25. North America Sodium Iodide (131I) for Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Sodium Iodide (131I) for Therapy Growth Accelerators and Market Barriers
 Table 27. Europe Sodium Iodide (131I) for Therapy Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Sodium Iodide (131I) for Therapy Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Sodium Iodide (131I) for Therapy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Sodium Iodide (131I) for Therapy Investment Opportunities and Key Challenges
 Table 31. Central and South America Sodium Iodide (131I) for Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Sodium Iodide (131I) for Therapy Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Sodium Iodide (131I) for Therapy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Curium Pharma Corporation Information
 Table 35. Curium Pharma Description and Major Businesses
 Table 36. Curium Pharma Product Features and Attributes
 Table 37. Curium Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Curium Pharma Revenue Proportion by Product in 2024
 Table 39. Curium Pharma Revenue Proportion by Application in 2024
 Table 40. Curium Pharma Revenue Proportion by Geographic Area in 2024
 Table 41. Curium Pharma Sodium Iodide (131I) for Therapy SWOT Analysis
 Table 42. Curium Pharma Recent Developments
 Table 43. HTA Co., Ltd. Corporation Information
 Table 44. HTA Co., Ltd. Description and Major Businesses
 Table 45. HTA Co., Ltd. Product Features and Attributes
 Table 46. HTA Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. HTA Co., Ltd. Revenue Proportion by Product in 2024
 Table 48. HTA Co., Ltd. Revenue Proportion by Application in 2024
 Table 49. HTA Co., Ltd. Revenue Proportion by Geographic Area in 2024
 Table 50. HTA Co., Ltd. Sodium Iodide (131I) for Therapy SWOT Analysis
 Table 51. HTA Co., Ltd. Recent Developments
 Table 52. Jubilant Pharmova Corporation Information
 Table 53. Jubilant Pharmova Description and Major Businesses
 Table 54. Jubilant Pharmova Product Features and Attributes
 Table 55. Jubilant Pharmova Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Jubilant Pharmova Revenue Proportion by Product in 2024
 Table 57. Jubilant Pharmova Revenue Proportion by Application in 2024
 Table 58. Jubilant Pharmova Revenue Proportion by Geographic Area in 2024
 Table 59. Jubilant Pharmova Sodium Iodide (131I) for Therapy SWOT Analysis
 Table 60. Jubilant Pharmova Recent Developments
 Table 61. PDRadiopharma Inc. Corporation Information
 Table 62. PDRadiopharma Inc. Description and Major Businesses
 Table 63. PDRadiopharma Inc. Product Features and Attributes
 Table 64. PDRadiopharma Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. PDRadiopharma Inc. Revenue Proportion by Product in 2024
 Table 66. PDRadiopharma Inc. Revenue Proportion by Application in 2024
 Table 67. PDRadiopharma Inc. Revenue Proportion by Geographic Area in 2024
 Table 68. PDRadiopharma Inc. Sodium Iodide (131I) for Therapy SWOT Analysis
 Table 69. PDRadiopharma Inc. Recent Developments
 Table 70. Yantai Dongcheng Pharmaceutical Group Co Corporation Information
 Table 71. Yantai Dongcheng Pharmaceutical Group Co Description and Major Businesses
 Table 72. Yantai Dongcheng Pharmaceutical Group Co Product Features and Attributes
 Table 73. Yantai Dongcheng Pharmaceutical Group Co Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Yantai Dongcheng Pharmaceutical Group Co Revenue Proportion by Product in 2024
 Table 75. Yantai Dongcheng Pharmaceutical Group Co Revenue Proportion by Application in 2024
 Table 76. Yantai Dongcheng Pharmaceutical Group Co Revenue Proportion by Geographic Area in 2024
 Table 77. Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy SWOT Analysis
 Table 78. Yantai Dongcheng Pharmaceutical Group Co Recent Developments
 Table 79. NTP Radioisotopes Corporation Information
 Table 80. NTP Radioisotopes Description and Major Businesses
 Table 81. NTP Radioisotopes Product Features and Attributes
 Table 82. NTP Radioisotopes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. NTP Radioisotopes Recent Developments
 Table 84. International Isotopes Inc Corporation Information
 Table 85. International Isotopes Inc Description and Major Businesses
 Table 86. International Isotopes Inc Product Features and Attributes
 Table 87. International Isotopes Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. International Isotopes Inc Recent Developments
 Table 89. ANSTO Corporation Information
 Table 90. ANSTO Description and Major Businesses
 Table 91. ANSTO Product Features and Attributes
 Table 92. ANSTO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. ANSTO Recent Developments
 Table 94. POLATOM（NCBJ） Corporation Information
 Table 95. POLATOM（NCBJ） Description and Major Businesses
 Table 96. POLATOM（NCBJ） Product Features and Attributes
 Table 97. POLATOM（NCBJ） Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. POLATOM（NCBJ） Recent Developments
 Table 99. Isotope JSC (Rosatom) Corporation Information
 Table 100. Isotope JSC (Rosatom) Description and Major Businesses
 Table 101. Isotope JSC (Rosatom) Product Features and Attributes
 Table 102. Isotope JSC (Rosatom) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Isotope JSC (Rosatom) Recent Developments
 Table 104. Raw Materials Key Suppliers
 Table 105. Distributors List
 Table 106. Market Trends and Market Evolution
 Table 107. Market Drivers and Opportunities
 Table 108. Market Challenges, Risks, and Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources


List of Figures
 Figure 1. Sodium Iodide (131I) for Therapy Product Picture
 Figure 2. Global Sodium Iodide (131I) for Therapy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Capsule Product Picture
 Figure 4. Solution Product Picture
 Figure 5. Global Sodium Iodide (131I) for Therapy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hyperthyroidism Treatment
 Figure 7. Thyroid Cancer Treatment
 Figure 8. Sodium Iodide (131I) for Therapy Report Years Considered
 Figure 9. Global Sodium Iodide (131I) for Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Sodium Iodide (131I) for Therapy Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Sodium Iodide (131I) for Therapy Revenue Market Share by Region (2020-2031)
 Figure 13. Global Sodium Iodide (131I) for Therapy Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Capsule Revenue Market Share by Player in 2024
 Figure 16. Solution Revenue Market Share by Player in 2024
 Figure 17. Global Sodium Iodide (131I) for Therapy Revenue Market Share by Type (2020-2031)
 Figure 18. Global Sodium Iodide (131I) for Therapy Revenue Market Share by Application (2020-2031)
 Figure 19. North America Sodium Iodide (131I) for Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players Sodium Iodide (131I) for Therapy Revenue (US$ Million) in 2024
 Figure 21. North America Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe Sodium Iodide (131I) for Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players Sodium Iodide (131I) for Therapy Revenue (US$ Million) in 2024
 Figure 28. Europe Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 31. France Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Sodium Iodide (131I) for Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players Sodium Iodide (131I) for Therapy Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 43. India Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore Sodium Iodide (131I) for Therapy Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America Sodium Iodide (131I) for Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players Sodium Iodide (131I) for Therapy Revenue (US$ Million) in 2024
 Figure 51. Central and South America Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil Sodium Iodide (131I) for Therapy Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina Sodium Iodide (131I) for Therapy Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa Sodium Iodide (131I) for Therapy Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players Sodium Iodide (131I) for Therapy Revenue (US$ Million) in 2024
 Figure 57. South America Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa Sodium Iodide (131I) for Therapy Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries Sodium Iodide (131I) for Therapy Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel Sodium Iodide (131I) for Therapy Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt Sodium Iodide (131I) for Therapy Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa Sodium Iodide (131I) for Therapy Revenue (2020-2025) & (US$ Million)
 Figure 63. Sodium Iodide (131I) for Therapy Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Sodium Iodide 131I Market Research Report 2024
Sodium Iodine 131I Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sodium Iodide I131 Solutions Market Research Report 2024
Global Sodium Iodide 131I Capsules Market Research Report 2024
Global Sodium Iodide I131 Solutions and Capsules Market Research Report 2024
Global Sodium Iodide 131I Therapy Capsules Market Research Report 2024
Global Sodium Iodide 131I Diagnostic Capsules Market Research Report 2024
Global Medical Radioactive Iodine I 131 Market Research Report 2024
Sodium Iodide 131I Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sodium Iodide 131 Diagnostic Capsule Market Research Report 2024
Global Sodium Iodide 131 Therapeutic Capsule Market Research Report 2024
Sodium Iodide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sodium Iodide I 131 Kits and Capsules Market Research Report 2025
Sodium Iodohippurate 131I Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Potassium Iodide Tablet Market Research Report 2025
Potassium Iodide Radiation Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Strontium Iodide Market Research Report 2024
Global Cesium Iodide Na Market Research Report 2025
Global Potassium Iodide Powder Market Research Report 2024
Global Iodine Supplements Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions